The lawsuit expenditure will not have a material impact but "Should the relevant patent families for Axiron be found to be invalid, then the result could be the potential launch of generic competition to Axiron in the United States, which would cause a decline in Axiron's net sales and the resulting royalties received by Acrux."
- Forums
- ASX - By Stock
- Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

The lawsuit expenditure will not have a material impact but...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $5.562K | 292.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 381825 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 60000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 381825 | 0.019 |
3 | 381800 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 60000 | 2 |
0.021 | 177000 | 1 |
0.022 | 18000 | 1 |
0.023 | 115126 | 4 |
0.024 | 254102 | 7 |
Last trade - 15.04pm 20/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |